CN Stock MarketDetailed Quotes

300759 Pharmaron Beijing

Watchlist

24.66
+0.28+1.15%

Market Closed Jan 6 15:00 CST

43.84BMarket Cap23.26P/E (TTM)

Pharmaron Beijing Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharmaron Beijing FY2024 9-Month Earnings Date

Currency：HKDOct 29, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	9.77B	--
		+6.37%
EPS	--	0.89	--
		+28.94%

Analyst Rating

Strong Buy

Jan 6, 2025

Pharmaron Beijing Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.318B	--
--	2024/Q4	-- / 3.270B	--
--	2024/Q3	3.213B / 3.442B	--
--	2024/Q2	2.934B / 3.196B	--
--	2024/Q1	2.671B / 2.883B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.318B--

--2024/Q4-- / 3.270B--

--2024/Q33.213B / 3.442B--

--2024/Q22.934B / 3.196B--

--2024/Q12.671B / 2.883B--

Unlock Free Earnings Estimates

Open Account

Pharmaron Beijing Earnings Reports

Kanglong Chemical: Report for the third quarter of 2024

Oct 29, 2024 12:00 ET

Kanglong Chemical: 2024 Semi-Annual Report

Aug 27, 2024 12:00 ET

Kanglong Chemical: 2024 Semi-Annual Report Summary

Aug 27, 2024 12:00 ET

Pharmaron Beijing: 2024 Interim Performance Forecast

Jul 21, 2024 12:00 ET

Symbol Price % Chg

Hangzhou Huasu Technology

301157

48.78 +20.00%

Suzhou Harmontronics Automation Technology

688022

12.30 +20.00%

Xinjiang Tianshan Animal Husbandry Bio-engineering

300313

6.43 +19.96%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 6, 2025

Strong Buy

Strong Buy
65.52%
Buy
31.03%
Hold
3.45%
Underperform
0.00%
Sell
0.00%

Price Target

No Data